A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity.
Sato-Kaneko F, Yao S, Lao FS, Shpigelman J, Messer K, Pu M, Shukla NM, Cottam HB, Chan M, Chu PJ, Burkhart D, Schoener R, Matsutani T, Carson DA, Corr M, Hayashi T.
Sato-Kaneko F, et al. Among authors: burkhart d.
Front Immunol. 2020 Jun 19;11:1207. doi: 10.3389/fimmu.2020.01207. eCollection 2020.
Front Immunol. 2020.
PMID: 32636840
Free PMC article.